| Dr Charles P Wilkinson, MD | |
|
6569 N Charles St, Suite 505, Baltimore, MD 21204-6831 | |
| (443) 849-2196 | |
| (443) 849-2648 |
| Full Name | Dr Charles P Wilkinson |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 6569 N Charles St, Baltimore, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477586816 | NPI | - | NPPES |
| 712L8765YBG | Other | MD | MEDICARE PIN |
| KJ54GB-52570101 | Other | MD | CAREFIRST OF MARYLAND GBM |
| S1410002 | Other | MD | CAREFIRST REGIONAL GBMC |
| 755691800 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | D09821 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles P Wilkinson, MD Po Box 418953, Boston, MA 02241-8953 Ph: () - | Dr Charles P Wilkinson, MD 6569 N Charles St, Suite 505, Baltimore, MD 21204-6831 Ph: (443) 849-2196 |
News Archive
A new addition to the cryogen-free, preclinical MRI imaging family, the 4.7T model, is now available to order. It joins the 3T and 7T systems for superior soft tissue contrast and molecular imaging research. This has been brought to the market by MR Solutions, the world's largest independent developer and manufacturer of commercially available MRI technology.
With 29 747 newly reported HIV infections in 2015, the EU/EEA notification rate is similar to recent years with an overall insignificant change from 6.6 per 100 000 population in 2006 to 6.3 in 2015 (adjusted for reporting delay).
The so-called "male lumpectomy" - a minimally invasive interventional radiology treatment for prostate cancer - is as effective as surgery in destroying diseased tumors and can be considered a first-line treatment for patients of all risk levels and particularly those who have failed radiation, according to studies released at the Society of Interventional Radiology's 34th Annual Scientific Meeting.
This week Nature Nanotechnology journal (October 12th) reveals how scientists from the London Centre for Nanotechnology (LCN) at University College London are using a novel nanomechanical approach to investigate the workings of vancomycin, one of the few antibiotics that can be used to combat increasingly resistant infections such as methicillin-resistant Staphylococcus aureus (MRSA).
› Verified 7 days ago
Dr. Pradeep Y Ramulu, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-6052 | |
Ashley Behrens, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 600 N. Wolfe Street, Baltimore, MD 21287 Phone: 410-502-0461 | |
Neil R Miller, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-5080 | |
Dr. Allan Griffiths Scott, M.D Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 6231 N Charles St, Baltimore, MD 21212 Phone: 410-377-2044 Fax: 410-377-8061 | |
Lily T Im, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 419 W Redwood St, Suite 479, Baltimore, MD 21201 Phone: 410-328-5918 Fax: 410-328-6346 | |
Brinda Muthusamy, MBCHB Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: The Wilmer Eye Institute Johns, 600 North Wolfe Street, Baltimore, MD 21287 Phone: 410-955-8314 | |
Israel Jesus Mendez, Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 600 N Wolfe St, Baltimore, MD 21264 Phone: 410-955-5080 |